4.7 Review

Eating disorders, gene-environment interactions and epigenetics

期刊

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
卷 35, 期 3, 页码 784-793

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.neubiorev.2010.09.012

关键词

Eating disorders; Risk factors; Epigenetics; Genes; Environment; Gene-environment interactions (GxE); Development

资金

  1. UK Department of Health NIHR [RP-PG-0606-1043]
  2. Multicentre EU Marie Curie Research Training Network
  3. INTACT [MRTN-CT-2006-035988]
  4. National Institute for Health Research (NIHR) Specialist Biomedical Research Centre for Mental Health
  5. Medical Research Council [G9817803B] Funding Source: researchfish

向作者/读者索取更多资源

This review describes the various subtypes of eating disorders and examines factors associated with the risk of illness. It considers evidence that the development and maintenance of eating disorders is due to gene-environment interactions (GxE) that alter genetic expression via epigenetic processes. It describes how environmental factors such as those associated with nutrition and/or stress may cause epigenetic changes which have transcriptional and phenotypic effects, which, in turn, alter the long term risk of developing an eating disorder. It reviews theoretical and practical issues associated with epigenetic studies in psychiatry and how these are relevant to eating disorders. It examines the limited number of epigenetic studies which have been conducted in eating disorders and suggests directions for further research. Understanding the relationship between epigenetic processes and the risk of an eating disorder opens possibilities for preventive and/or therapeutic interventions. For example, epigenetic changes associated with diet and weight may be reversible and those associated with cognitive processes may be accessible to pharmacological interventions.(C) 2010 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Psychology, Clinical

Attention-deficit/hyperactivity disorder and other neurodevelopmental disorders in offspring of parents with depression and bipolar disorder

L. Propper, A. Sandstrom, S. Rempel, E. Howes Vallis, S. Abidi, A. Bagnell, D. Lovas, M. Alda, B. Pavlova, R. Uher

Summary: Offspring of parents with bipolar disorder or major depressive disorder have higher rates of neurodevelopmental disorders, particularly attention-deficit/hyperactivity disorder.

PSYCHOLOGICAL MEDICINE (2023)

Article Psychology, Clinical

Dimensions of temperament and character as predictors of antidepressant discontinuation, response and adverse reactions during treatment with nortriptyline and escitalopram

Ole Koehler-Forsberg, Robert Keers, Rudolf Uher, Joanna Hauser, Wolfgang Maier, Marcella Rietschel, Peter McGuffin, Anne E. Farmer, Katherine J. Aitchison, Ole Mors

Summary: This study suggests that there may be correlations between personality traits and antidepressant treatment response, but these correlations may be confounded by differential rates of discontinuation.

PSYCHOLOGICAL MEDICINE (2023)

Article Neurosciences

Response Inhibition and Predicting Response to Pharmacological and Cognitive Behavioral Therapy Treatments for Major Depressive Disorder: A Canadian Biomarker Integration Network for Depression Study

Prabhjot Dhami, Lena C. Quilty, Benjamin Schwartzmann, Rudolf Uher, Timothy A. Allen, Stefan Kloiber, Raymond W. Lam, Glenda MacQueen, Benicio N. Frey, Roumen Milev, Daniel J. Mueller, Stephen C. Strother, Pierre Blier, Claudio N. Soares, Sagar V. Parikh, Gustavo Turecki, Jane A. Foster, Susan Rotzinger, Sidney H. Kennedy, Faranak Farzan

Summary: The neurobiological correlates of response inhibition can predict the response of patients with major depressive disorder (MDD) to pharmacological and cognitive behavioral therapy treatment. The integrity of response inhibition may be crucial for the success of treatment for MDD. Electrophysiological correlates of response inhibition may serve as a general prognostic marker for treatment response in MDD.

BIOLOGICAL PSYCHIATRY-COGNITIVE NEUROSCIENCE AND NEUROIMAGING (2023)

Article Psychology, Clinical

Prediction of depression treatment outcome from multimodal data: a CAN-BIND-1 report

Mehri Sajjadian, Rudolf Uher, Keith Ho, Stefanie Hassel, Roumen Milev, Benicio N. Frey, Faranak Farzan, Pierre Blier, Jane A. Foster, Sagar Parikh, Daniel J. Mueller, Susan Rotzinger, Claudio N. Soares, Gustavo Turecki, Valerie H. Taylor, Raymond W. Lam, Stephen C. Strother, Sidney H. Kennedy

Summary: Predicting treatment outcomes for major depressive disorder can be improved by combining clinical, neuroimaging, and molecular data. Early measurement during treatment can increase precision, but adding more features does not necessarily enhance prediction accuracy.

PSYCHOLOGICAL MEDICINE (2023)

Article Health Policy & Services

Designing genetic studies for people with intellectual disabilities: Practical lessons from a pilot study

Adrian Sellers, Sharon Hudson, Joanna Ledger, Charlotte Moorehouse, Charlotte Young, Ian Groeber, Bridget Knight, Jonathan Mill, Jon Allard, Rohit Shankar

Summary: Genetic variations in people with intellectual disability (PwID) are under-diagnosed. This pilot genetic study aimed to address this issue, but faced challenges in obtaining consent and recruitment. However, the study found that 75% of PwID had biochemical abnormalities requiring further medical attention, highlighting the clinical benefits of engagement.

JOURNAL OF POLICY AND PRACTICE IN INTELLECTUAL DISABILITIES (2023)

Article Biochemistry & Molecular Biology

Uncertainty quantification of reference-based cellular deconvolution algorithms

Dorothea Seiler Vellame, Gemma Shireby, Ailsa MacCalman, Emma L. Dempster, Joe Burrage, Tyler Gorrie-Stone, Leonard S. Schalkwyk, Jonathan Mill, Eilis Hannon

Summary: Most epigenetic epidemiology studies have used bulk tissues for genome-wide profiling, but these can be confounded by variation in cellular composition. In this study, researchers developed a metric called CETYGO score to assess the accuracy of derived cellular heterogeneity variables. They found that the CETYGO score can distinguish inaccurate deconvolutions when applied to whole blood profiles. The study also revealed that estimating accurate cellular composition is influenced by technical and biological factors, such as gender, age, and smoking status.

EPIGENETICS (2023)

Article Clinical Neurology

Epigenetic age acceleration is associated with oligodendrocyte proportions in MSA and control brain tissue

Megha Murthy, Gemma Shireby, Yasuo Miki, Emmanuelle Vire, Tammaryn Lashley, Thomas T. Warner, Jonathan Mill, Conceicao Bettencourt

Summary: This study investigated the epigenetic aging in white matter for the first time, and found that oligodendrocyte proportions positively influence epigenetic age acceleration.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2023)

Article Endocrinology & Metabolism

Genome-wide characterization of mitochondrial DNA methylation in human brain

Matthew Devall, Darren M. Soanes, Adam R. Smith, Emma L. Dempster, Rebecca G. Smith, Joe Burrage, Artemis Iatrou, Eilis Hannon, Claire Troakes, Karen Moore, Paul O'Neill, Safa Al-Sarraj, Leonard Schalkwyk, Jonathan Mill, Michael Weedon, Katie Lunnon

Summary: This study presents a novel approach to investigate the patterns of mitochondrial DNA methylation in human brain tissue. The results show relatively low but conserved patterns of mitochondrial DNA methylation, with peaks observed in the D-LOOP and several genes in a non-CpG context. Differential methylation patterns associated with age, sex, and brain region were also identified. This study provides detailed annotation of DNA methylation in the mitochondrial genome and highlights the potential role of mitochondrial epigenetic mechanisms in disorders characterized by mitochondrial dysfunction.

FRONTIERS IN ENDOCRINOLOGY (2023)

Article Psychiatry

Polygenic Scores and Onset of Major Mood or Psychotic Disorders Among Offspring of Affected Parents

Alyson Zwicker, Janice M. Fullerton, Niamh Mullins, Frances Rice, Danella M. Hafeman, Neeltje E. M. van Haren, Nikita Setiaman, John A. Merranko, Benjamin I. Goldstein, Alessandra G. Ferrera, Emma K. Stapp, Elena de la Serna, Dolores Moreno, Gisela Sugranyes, Sergio Mas Herrero, Gloria Roberts, Claudio Toma, Peter R. Schofield, Howard J. Edenberg, Holly C. Wilcox, Melvin G. McInnis, Victoria Powell, Lukas Propper, Eileen Denovan-Wright, Guy Rouleau, Josefina Castro-Fornieles, Manon H. J. Hillegers, Boris Birmaher, Anita Thapar, Philip B. Mitchell, Cathryn M. Lewis, Martin Alda, John I. Nurnberger, Rudolf Uher

Summary: The authors found that polygenic scores (PGSs) can complement family history to improve identification of risk for major mood and psychotic disorders. PGSs for neuroticism and subjective well-being are significantly associated with the onsets of disorders, and PGSs for psychiatric illness have limited predictive power when family history is known.

AMERICAN JOURNAL OF PSYCHIATRY (2023)

Article Psychiatry

The Differential Relation of Emotional, Physical, and Sexual Abuse Histories to Antidepressant Treatment Remission and Persistence of Anhedonia in Major Depression: A CAN-BIND-1 Report

Kate L. Harkness, Trisha Chakrabarty, Sakina J. Rizvi, Raegan Mazurka, Lena Quilty, Rudolf Uher, Roumen V. Milev, Benicio N. Frey, Sagar V. Parikh, Jane A. Foster, Susan Rotzinger, Sidney H. Kennedy, Raymond W. Lam

Summary: This study aims to investigate the differential associations of different types of childhood maltreatment with the response to antidepressant medication, and the role of anhedonia in driving poor response in patients with specific maltreatment histories. The results suggest that the severity of emotional maltreatment perpetrated by the mother is a significant predictor of lower odds of remission at week 16. In contrast, the relationships between paternal-perpetrated emotional maltreatment and physical maltreatment with week 16 remission were mediated through the severity of anhedonia at week 8.

CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2023)

Article Psychiatry

Response trajectories during escitalopram treatment of patients with major depressive disorder

John-Jose Nunez, Yang S. Liu, Bo Cao, Benicio N. Frey, Keith Ho, Roumen Milev, Daniel J. Mueller, Susan Rotzinger, Claudio N. Soares, Valerie H. Taylor, Rudolf Uher, Sidney H. Kennedy, Raymond W. Lam

Summary: Depression is a complex disorder with a heterogeneous response to treatment. This study used machine learning to cluster patients with depression and found three distinct response patterns. The subjective mood state/anhedonia was identified as the core feature of response to escitalopram, but there were also other patterns related to neurovegetative symptoms, activation, and cognition.

PSYCHIATRY RESEARCH (2023)

Article Psychiatry

Transdiagnostic risk of mental disorders in offspring of affected parents: a meta-analysis of family high-risk and registry studies

Rudolf Uher, Barbara Pavlova, Joaquim Radua, Umberto Provenzani, Sara Najafi, Lydia Fortea, Maria Ortuno, Anna Nazarova, Nader Perroud, Lena Palaniyappan, Katharina Domschke, Samuele Cortese, Paul D. Arnold, Jehannine C. Austin, Michael M. Vanyukov, Myrna M. Weissman, Allan H. Young, Manon H. J. Hillegers, Andrea Danese, Merete Nordentoft, Robin M. Murray, Paolo Fusar-Poli

Summary: The offspring of parents with mental disorders have an increased risk of developing mental disorders themselves, extending beyond the specific disorders present in their parents. This comprehensive meta-analysis provides important insights for targeted prevention and genetic counseling.

WORLD PSYCHIATRY (2023)

Review Biotechnology & Applied Microbiology

An overview of DNA methylation-derived trait score methods and applications

Marta F. Nabais, Danni A. Gadd, Eilis Hannon, Jonathan Mill, Allan F. McRae, Naomi R. Wray

Summary: Microarray technology is employed to analyze genome-wide DNA methylation and its association with complex traits or diseases. Results can be used to predict outcomes using methylation profile scores (MPS) in independent datasets. However, there are key differences between MPS and polygenic (risk) scores (PGS), especially in terms of assumptions made in genetic modeling that may not apply to epigenetic data.

GENOME BIOLOGY (2023)

Article Psychiatry

Predicting recurrence of major depressive episodes using the Depression Implicit Association Test: A Canadian biomarker integration network in depression (CAN-BIND) report

Katerina Rnic, Joelle Lemoult, Ivan J. Torres, Trisha Chakrabarty, Jane Foster, Benicio N. Frey, Kate L. Harkness, Keith Ho, Qingqin S. Li, Roumen Milev, Lena C. Quilty, Susan Rotzinger, Claudio N. Soares, Rudolf Uher, Sidney H. Kennedy, Raymond W. Lam

Summary: Implicit self-depressed associations (SDAs) may serve as a cognitive biomarker for predicting depression recurrence, as higher baseline SDAs and increasing SDAs over time were found to be associated with shorter time to MDD recurrence among treatment responders.

PSYCHIATRY RESEARCH (2023)

Article Behavioral Sciences

Success versus failure in cognitive control: Meta-analytic evidence from neuroimaging studies on error processing

Edna C. Cieslik, Markus Ullsperger, Martin Gell, Simon B. Eickhoff, Robert Langner

Summary: Previous studies on error processing have primarily focused on the posterior medial frontal cortex, but the role of other brain regions has been underestimated. This study used activation likelihood estimation meta-analyses to explore brain activity related to committing errors and responding successfully in interference tasks. It was found that the salience network and the temporoparietal junction were commonly involved in both correct and incorrect responses, indicating their general involvement in coping with situations that require increased cognitive control. Error-specific convergence was observed in the dorsal posterior cingulate cortex, posterior thalamus, and left superior frontal gyrus, while successful responding showed stronger convergence in the dorsal attention network and lateral prefrontal regions. Underrecruitment of these regions in error trials may reflect failures in activating the appropriate stimulus-response contingencies necessary for successful response execution.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2024)